login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
EXACT SCIENCES CORP (EXAS) Stock News
USA
- NASDAQ:EXAS -
US30063P1057
-
Common Stock
53.32
USD
-0.27 (-0.5%)
Last: 9/19/2025, 8:01:27 PM
53.32
USD
0 (0%)
After Hours:
9/19/2025, 8:01:27 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
EXAS Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Benzinga
Peering Into Exact Sciences's Recent Short Interest
6 days ago - By: Zacks Investment Research
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
9 days ago - By: Benzinga
Demystifying Exact Sciences: Insights From 9 Analyst Reviews
11 days ago - By: Zacks Investment Research
- Mentions:
MASI
PAHC
NVST
Should You Continue to Hold EXAS Stock in Your Portfolio?
11 days ago - By: Exact Sciences Corp.
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
16 days ago - By: Zacks Investment Research
- Mentions:
GH
TEM
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
16 days ago - By: Investor's Business Daily
- Mentions:
GH
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run
a month ago - By: Exact Sciences Corp.
Exact Sciences to Participate in September Investor Conferences
a month ago - By: Zacks Investment Research
- Mentions:
TMO
ILMN
GH
TMO Receives FDA Approval for Oncomine Dx Target Test
a month ago - By: Zacks Investment Research
- Mentions:
GH
TEM
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
a month ago - By: Zacks Investment Research
- Mentions:
BSX
MEDP
WGS
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
a month ago - By: The Motley Fool
- Mentions:
TTD
PINS
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
a month ago - By: Zacks Investment Research
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
a month ago - By: Zacks Investment Research
- Mentions:
AZN
IRWD
ABBV
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
a month ago - By: Zacks Investment Research
- Mentions:
PBYI
CRMD
IMCR
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
2 months ago - By: Zacks Investment Research
- Mentions:
VTGN
Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates
Please enable JavaScript to continue using this application.